Company Filing History:
5 out of 1,743 
4 out of 124 
3 out of 154 
Years Active: 2018-2024
Title: Aurelien Olichon: Innovator in Antibody Research
Introduction
Aurelien Olichon is a prominent inventor based in Toulouse, France. He has made significant contributions to the field of antibody research, holding a total of five patents. His work focuses on the development of synthetic single domain antibodies and their applications in therapeutics.
Latest Patents
One of his latest patents is titled "Synthetic single domain antibody." This invention pertains to the identification of a highly stable single domain antibody scaffold (hs2dAb) and its use in generating a synthetic single domain antibody library (hs2dAb-L1). The invention also encompasses antigen-binding proteins that utilize this stable scaffold, particularly for therapeutic purposes. Another notable patent is "Anti-rho GTPase conformational single domain antibodies and uses thereof." This invention relates to active form-specific anti-Rho GTPase conformational single domain antibodies and their applications in therapeutic and diagnostic fields. It specifically details a single domain antibody with amino acid sequences that exhibit at least 90% identity with established sequences from various single domain antibodies.
Career Highlights
Aurelien Olichon has worked with esteemed institutions such as the National Institute of Health and Medical Research and Institut Curie. His research has significantly advanced the understanding and application of single domain antibodies in medical science.
Collaborations
Throughout his career, Aurelien has collaborated with notable colleagues, including Sandrine Moutel and Franck Perez. These partnerships have further enriched his research and innovation in the field.
Conclusion
Aurelien Olichon stands out as a key figure in the development of innovative antibody technologies. His patents and collaborations reflect his commitment to advancing therapeutic solutions through scientific research.